Catherine Jones

Title: The Innovative Contributions of Catherine Jones

Introduction

Catherine Jones is a prominent inventor based in Burnaby, Canada. She has made significant strides in the field of ophthalmic drug delivery systems. With a total of 3 patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

Catherine's latest patents include a groundbreaking ophthalmic drug sustained release formulation. This solid matrix sustained release formulation is designed for the topical delivery of a solid ophthalmic drug to the eye. It encompasses medical devices, drug cores, drug inserts, and drug delivery systems that utilize this formulation. The methods of manufacturing the formulation are also detailed, along with the medical devices and their methods for delivering the ophthalmic drug over a specified treatment period. The formulation is an admixture of an ophthalmic drug combined with a hydrophobic polymer, a hydrophilic polymer, and a surfactant. This innovative approach allows the drug to be eluted daily over an extended period at a therapeutic dose.

Career Highlights

Catherine is currently employed at Mati Therapeutics Inc., where she continues to develop her innovative ideas. Her work focuses on enhancing the efficacy of drug delivery systems, particularly in ophthalmology.

Collaborations

Catherine collaborates with talented individuals such as Deepank Utkhede and David Wiseman, contributing to a dynamic and innovative work environment.

Conclusion

Catherine Jones is a remarkable inventor whose contributions to ophthalmic drug delivery systems are noteworthy. Her patents reflect her commitment to improving medical treatments and enhancing patient care.